Aldehyde dehydrogenase activity as a functional marker for lung cancer

Chemico-Biological Interactions

Volumn 178, Issue 1-3, 2009, Pages 48-55

  Ucar, Deniz ^a   Cogle, Christopher R ^a   Zucali, James R ^a   Ostmark, Blanca ^a   Scott, Edward W ^a   Zori, Robert ^a   Gray, Brian A ^a   Moreb, Jan S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

ALDH; Lung cancer; Stem cell; Xenografts

Indexed keywords

ALDEHYDE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL SELECTION; CELL STRUCTURE; CELL SUSPENSION; CELL TYPE; CYTOGENETICS; DILUTION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG CANCER; MOLECULAR CLONING; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; SCID MOUSE; STEM CELL; TUMOR VOLUME; TUMOR XENOGRAFT;

ALDEHYDE DEHYDROGENASE; ANIMALS; CELL LINE, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; MUS;

EID: 59049095990     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.09.029     Document Type: Article

References (45)

1. Sládek N.E., Kollander R., Sreerama L., and Kiang D.T. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens. Cancer Chemother. Pharmacol. 49 (2002) 309-321
2. Vasiliou V., Pappa A., and Estey T. Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug Metab. Rev. 35 (2004) 279-299
3. Pietruszko P. Aldehyde dehydrogenase isozymes. Curr. Top. Biol. Med. Res. 8 (1983) 195-217
4. Agarwal D.P., and Goedde H.W. Human aldehyde dehydrogenase isozymes and alcohol sensitivity. In: Rattazzi M.C., Scandalios J.G., and Whitt G.S. (Eds). Isozymes: Current Topics in Biological and Medical Research. Agriculture, Physiology, and Medicine 16 (1987), Alan R Liss, New York 21-48
5. Sladek N.E., Manthey C.L., Maki P.A., Zhang Z., and Landkamer G.J. Xenobiotic oxidation catalyzed by aldehyde dehydrogenases. Drug Metab. Rev. 20 (1989) 697-720
6. Goedde H.W., and Agarwal D.P. Pharmacogenetics of aldehyde dehydrogenase (ALDH). Pharmacol. Ther. 45 (1990) 345-371
7. Lindahl R. Aldehyde dehydrogenases and their role in carcinogenesis. Crit. Rev. Biochem. Mol. Biol. 27 (1992) 283-335
8. Yoshida A., Rzhetsky A., Hsu L.C., and Chang C. Human aldehyde dehydrogenase gene family. Eur. J. Biochem. 251 (1998) 549-557
9. Sladek N.E. Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines. Curr. Pharm. Des. 5 (1999) 607-625
10. Vasiliou V., Pappa A., and Petersen D.R. Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. Chem. Biol. Interact. 129 (2000) 1-19
11. Moreb J.S., Maccow C., Schweder M., and Hecomovich J. Expression of antisense RNA to aldehyde dehydrogenase class-1 sensitizes tumor cells to 4-hydroperoxycyclophosphamide in vitro. J. Pharmacol. Exp. Ther. 293 (2000) 390-396
12. Moreb J.S., Muhoczy D., Ostmark B., and Zucali J.R. RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide. Cancer Chemother. Pharmacol. 59 (2006) 127-136
13. Chute J.P., Muramoto G.G., Whitesides J., Colvin M., Safi R., Chao N.J., and McDonnell D.P. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 11707-11712
14. Wickström M., Danielsson K., Rickardson L., Gullbo J., Nygren P., Isaksson A., Larsson R., and Lovborg H. Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients. Biochem. Pharmacol. 73 (2007) 25-33
15. Niederreither K., McCaffery P., Drager U.C., Chambon P., and Dolle P. Restricted expression and retinoic acid-induced downregulation of the retinaldehyde dehydrogenase type 2 (RALDH-2) gene during mouse development. Mech. Dev. 62 (1997) 67-78
16. Niederreither K., Subbarayan V., Dolle P., and Chambon P. Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat. Genet. 21 (1999) 444-448
17. Dupe V., Matt N., Garnier J.M., Chambon P., Mark M., and Ghyselinck N.B. A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 14036-14041
18. Lassen N., Bateman J.B., Estey T., Kuszak J.R., Nees D.W., Piatigorsky J., Duester G., Day B.J., Huang J., Hines L.M., and Vasiliou V. Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in ALDH3A1 (-/-)/ALDH1A1 (-/-) knock-out mice. J. Biol. Chem. 282 (2007) 25668-25676
19. Cortez M.A., Wu Y., Gibson K.M., and Snead III O.C. Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy. Pharmacol. Biochem. Behav. 79 (2004) 547-553
20. Chang C., Hsu L.C., Dave V.V., and Yoshida A. Expression of human aldehyde dehydrogenase-3 associated with hepatocellular carcinoma: promoter regions and nuclear protein factors related to the expression. Int. J. Mol. Med. 2 (1998) 333-338
21. Ma S., Chan K., Lee T.K., Tang K., Wo J.Y., Zheng B., and Guan X. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol. Cancer Res. 6 (2008) 1146-1153
22. Feldmann G., Dhara S., Fendrich V., Bedja D., Beaty R., Mullendore M., Karikari C., Alvarez H., Iacobuzio-Donahue C., Jimeno A., Gabrielson K.L., Matsui W., and Maitra A. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res. 67 (2007) 2187-2196
23. Korkaya H., Paulson A., Iovino F., and Wicha M.S. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene (2008) [Epub ahead of print]
24. Okamura S., Ng C.C., Koyama K., Takei Y., Arakawa H., Monden M., and Nakamura Y. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncology Res. 11 (1999) 281-285
25. Sladek N.E. Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact. J. Biochem. Mol. Toxicol. 17 (2003) 7-23
26. Moreb J.S., Zucali J.R., Ostmark B., and Benson N.A. Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay. Cytomet. B. Clin. Cytomet. 72 (2007) 281-289
27. Patel M., Lu L., Zander D.S., Sreerama L., Coco D., and Moreb J.S. ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer 59 (2008) 340-349
28. Kastan M.B., Schlaffer E., Russo J.E., Colvin O.M., Civin C.I., and Hilton J. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Blood 75 (1990) 1947-1950
29. Storms R.W., Trujillo A.P., Springer J.B., Shah L., Colvin O.M., Ludeman S.M., and Smith C. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc. Natl. Acad. Sci. Cell Biol. 96 (1999) 9118-9123
30. Bunting K.D., Lindahl R., and Townsend A.J. Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase. J. Biol. Chem. 269 (1994) 23197-23203
31. Bunting K.D., and Townsend A.J. De novo expression of transfected human class 1 aldehyde dehydrogenase (ALDH) causes resistance to oxazaphosphorine anti-cancer alkylating agents in hamster V79 cell lines. Elevated class 1 ALDH activity is closely correlated with reduction in DNA interstrand cross-linking and lethality. J. Biol. Chem. 271 (1996) 11884-11890
32. Moreb J., Schweder M., Suresh A., and Zucali J.R. Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide. Cancer Gene Ther. 3 (1996) 24-30
33. Moreb J.S., Schweder M., Gray B., Zucali J., and Zori R. In vitro selection for K562 cells with higher retrovirally mediated copy number of aldehyde dehydrogenase class-1 and higher resistance to 4-hydroperoxycyclophosphamide. Hum. Gene Ther. 9 (1998) 611-619
34. Storms S.W., Green P.D., Safford K.M., Niedzwiecki D., Cogle C.R., Colvin O.M., Chao N.J., Rice H.E., and Smith C.A. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood 106 (2005) 95-102
35. Cheung A.M., Wan T.S., Leung J.C., Chan L.Y., Huang H., Kwong Y.L., Liang R., and Leung A.Y. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia 21 (2007) 1423-1430
36. Matsui W., Wang Q., Barber J.P., Brennan S., Smith B.D., Borrello I., McNiece I., Lin L., Ambinder R.F., Peacock C., Watkins D.N., Huff C.A., and Jones R.J. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res. 68 (2008) 190-197
37. Ginestier C., Hur M.H., Charafe-Jauffret E., Moneville F., Dutcher J., Brown M., Jacquemier J., Viems P., Kleer C.G., Liu S., Schott A., Haves D., Birnbaum D., Wicha M.S., and Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 1 (2007) 555-567
38. M.R. Clay, M.H. Tabor, C.R. Bradford, et al., Aldehyde dehydrogenase isolates cancer stem cells in head and neck squamous cell carcinoma [abstract], in: Proceedings of the American Association for Cancer Research Annual Meeting, (Abstract no. 1291), Los Angeles, CA, Apr 14-18, 2007.
39. Seabright M. A rapid banding technique for human chromosomes. Lancet 2 (1971) 971-972
40. Ezeh U.I., Tirek P.J., Reijo R.A., and Clark A.T. Human embryonic stem cell gene OCT4, NANOG, Stellar, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104 (2005) 2256-2265
41. Gibbs C.P., Kukekov V.G., Reith J.D., Tchigrinova O., Suslov O.N., Scott E.W., Ghivizzani S.C., Ignatova T.N., and Steindler D.A. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 7 (2005) 967-976
42. Barrandon Y., and Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 2302-2306
43. Locke M., Heywood M., Fawell S., and Mackenzie I.C. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res. 65 (2005) 8944-8950
44. Kiel M.J., Yilmaz O.H., Iwashita T., Yilmaz O.H., Terhorst C., and Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121 (2005) 1109-1121
45. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., Oh E.Y., Gaber M.W., Finklestein D., Allen M., Frank A., Bayazitov I.T., Zakharenko S.S., Gajjar A., Davidoff A., and Gilbertson R.J. A perivascular niche for brain tumor stem cells. Cancer Cell 11 (2007) 69-82